Cargando…
DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition
In this work, we have developed a truncated DNA aptamer, termed XQ-2d, with high affinity and specificity for pancreatic ductal adenocarcinoma (PDAC). Aptamer XQ-2d selectively binds to PL45 cells with a dissociation constant in the nanomolar range, as determined by its recognition of PL45 tumor cel...
Autores principales: | Wu, Xiaoqiu, Zhao, Zilong, Bai, Huarong, Fu, Ting, Yang, Chao, Hu, Xiaoxiao, Liu, Qiaoling, Champanhac, Carole, Teng, I-Ting, Ye, Mao, Tan, Weihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493536/ https://www.ncbi.nlm.nih.gov/pubmed/26155314 http://dx.doi.org/10.7150/thno.11938 |
Ejemplares similares
-
Development of a panel of DNA Aptamers with High Affinity for Pancreatic Ductal
Adenocarcinoma
por: Champanhac, Carole, et al.
Publicado: (2015) -
Molecular Recognition of Human Liver Cancer Cells Using DNA Aptamers Generated via Cell-SELEX
por: Xu, Jiehua, et al.
Publicado: (2015) -
Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma
por: Li, Q., et al.
Publicado: (2020) -
Selection and characterization of DNA aptamer for metastatic prostate cancer recognition and tissue imaging
por: Duan, Minlan, et al.
Publicado: (2016) -
Aptamer‐SH2 superbinder‐based targeted therapy for pancreatic ductal adenocarcinoma
por: Liu, An‐Dong, et al.
Publicado: (2021)